English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Psoriasis is a skin disease mainly developed in humans, although it is also seen in mon‐ keys and dogs. Animal models with psoriasis‐like lesions have been a key factor for its understanding. Xenotransplants of human psoriatic skin in immunodeficient mice were the first approach for the association of immunologic problems with the development of psoriasis and have been also useful for the evaluation on new therapeutic agents. Imiquimod‐induced murine psoriasis is nowadays one of the most used animal models to study this disease, perhaps because healthy wild‐type mice are used, which means that it is an affordable model, easy to generate, and, more importantly, resembles the inflam‐ matory, angiogenic and hyperproliferative characteristics of human psoriasis. Several transgenic (over‐expressing VEGF, Tie2, TGFβ, STAT3, IL‐36, PPARβ/γ) and knockout (lacking IκBα, JunB, IFNR‐2, IL‐36RA, CD18, IKK2) mice have been useful for the associa‐ tion of specific molecules for the development of psoriasis. Other approach has been the use of both transgenic/knockout mice and imiquimod treatment, where the importance of βTrCP, IκBζ, IL‐35 and Tnip1 for the development of psoriasis was found. In this chap‐ ter, some of these animal models are discussed.

Psoriatic Animal Models Developed for the Study of the Disease